NCT00346749 · Interventional trial
ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.
Overall registry status Terminated
Phase 4
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory